Fapon to Unveil the Shine mT8000: A Game-Changer for Clinical Laboratories
Fapon, a prominent global force in the life sciences sector, is set to showcase its latest innovation, the
Shine mT8000, at the upcoming
ADLM 2025 Annual Scientific Meeting. This revolutionary tool is designed to streamline clinical laboratories’ operations by combining high throughput capabilities with an open and efficient diagnostic platform.
A Step Toward Enhanced Efficiency in Clinical Testing
The Shine mT8000 is a cutting-edge
Fully Automated Clinical Chemistry and Immunoassay System that promises to redefine the approach to laboratory diagnostics. Spanning just
5 square meters, this compact unit merges biochemistry and immunoassay functions into a singular platform, making it ideal for modern laboratory environments challenged by space constraints.
Equipped to handle an impressive
735 tests per hour, the mT8000 system demonstrates Fapon's commitment to providing advanced solutions that meet the growing demands of clinical chemistry and immunoassays. This system will not only augment efficiency but also improve accuracy and reliability in diagnostics.
Exceptional Features Packed into a Single Unit
The
Shine mT8000 boasts several groundbreaking features:
- - Ultra-Fast Testing with Dual Engine: This capability allows the analyzer to perform 2,400 tests per hour in biochemistry, along with 600 tests per hour in electrolytes and 900 tests per hour in immunoassays. It supports full-process testing directly from whole blood samples, significantly enhancing workflow agility and speed.
- - Modular Design: Laboratories can customize their mT8000 setups according to specific testing needs by integrating various modules for biochemistry and immunoassay services. This flexibility ensures that labs can scale their operations to meet demand.
- - Smart Automation and Safety Features: The mT8000 incorporates AI-driven monitoring systems for precise sample tracking and error detection. Features such as automated maintenance and bio-safety enhancements reduce the need for manual handling, contributing to laboratory safety and efficiency.
- - Open and Compatible Ecosystem: The design acknowledges the interoperability requirements of modern labs, with support for four major chemiluminescence systems. This ensures that facilities can seamlessly integrate existing technologies with new solutions, optimizing their workflow.
Fapon’s Ongoing Commitment to Transformation
The introduction of the Shine mT8000 aligns with Fapon's broader mission to foster a comprehensive and intelligent diagnostic ecosystem. The company's expansive portfolio now includes a range of CLIA analyzers, addressing varying throughput requirements while ensuring that over 8,000 units are utilized across the globe.
Fapon’s pioneering efforts extend to its extensive range of innovative reagents, which currently includes over
70 self-developed CLIA assays, with plans to expand this number to over
200. This positioning in the marketplace is further enhanced by the provision of
One-Stop Solutions that support laboratories with everything from open platform instruments to rapid reagent development and quality raw materials.
Engage with Fapon at ADLM 2025
ADLM 2025 attendees are encouraged to visit Fapon's booth
3816 to witness the official launch of the Shine mT8000. It’s a unique opportunity to see firsthand how this analyzer can transform laboratory diagnostics and take efficiency to new heights.
About Fapon
Fapon has established itself as a leader in offering integrated diagnostic solutions, biopharma, and biotherapy services on a global scale. With a diverse product lineup supported by cutting-edge technology and an expansive operational network, Fapon's offerings are designed to meet the evolving needs of clinical laboratories across
over 70 countries. To learn more about Fapon and its innovative solutions, visit their
website or connect on LinkedIn (Fapon).